Publication | Open Access
P1.17-07 Neoadjuvant Gefitinib in Resectable Early Stage EGFR Mutant Non-Small Cell Lung Cancer (NSCLC): A Window-of-Opportunity Study
11
Citations
0
References
2019
Year
Surgical OncologyMedicinePathologyP1.17-07 Neoadjuvant GefitinibWindow-of-opportunity StudyCancer TreatmentCancer GeneticsOncologyRadiation OncologyLung CancerMolecular Oncology
No additional data available for this publication yet. Check back later!